Antibacterial and Toxicity Evaluation of Eastern Medicine Formulation Eczegone for the Management of Eczema
Open Access
- 1 July 2020
- journal article
- research article
- Published by SAGE Publications in Dose-Response
- Vol. 18 (3)
Abstract
The present study was conducted to evaluate the antibacterial activity, in vitro and in vivo cytotoxicity, cell viability and safety of Eastern Medicine coded medicinal formulation Eczegone comprising extracts of Azadirachta indica (Azin), Fumaria indica (Fuin), Sphaeranthus indicus (Spin) and Lawsonia inermis (Lain). This work also evaluated antibacterial activity of Eczegone formulation having above mentioned plants ethanolic extracts against different bacteria’s by disk diffusion method. In vitro toxicity of Eczegone formulation was investigated by using human skin keratinocytes HaCaT cell line, crystal violet stained cells, and methyl tetrazolium cytotoxicity (MTT) assay. In vivo acute oral and dermal cytotoxicity was determined by using Swiss albino mice and albino rabbits, respectively. The Eczegone formulation showed antibacterial activity against 3 gram negative bacteria including Escherichia coli, Klebsiella pneumonia, Proteus vulgaris and a gram positive Staphylococcus aureus. We didn’t observe any toxic effect of Eczegone formulation on the skin keratinocytes. Furthermore, the Ezcegone formulation was non-irritant according to draize score (OECD TG404, 2002). After rigorous safety evaluation by in vitro and in vivo acute oral and dermal toxicity analysis, we concluded that Eczegone formualtion possessses antibacterial effects and is safe, non-toxic, non-irritant, and the drug would be subjected for further biochemical and clinical studies.Keywords
This publication has 55 references indexed in Scilit:
- Immunology of atopic eczema: overcoming the Th1/Th2 paradigmAllergy, 2013
- Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological StudiesPLOS ONE, 2012
- Antioxidant constituents from Lawsonia inermis leaves: Isolation, structure elucidation and antioxidative capacityFood Chemistry, 2011
- Recent insights into atopic dermatitis and implications for management of infectious complicationsJournal of Allergy and Clinical Immunology, 2010
- Antitumoral Effect of L. inermis in Mice with EACInternational Journal of Pharmacology, 2009
- The evidence based wound healing activity of Lawsonia inermis Linn.Phytotherapy Research, 2007
- Anti-inflammatory and anti-nociceptive activities of Fumaria indica whole plant extract in experimental animalsActa Pharmaceutica, 2007
- Antiviral activities of some Ethiopian medicinal plants used for the treatment of dermatological disordersJournal of Ethnopharmacology, 2006
- In vitro tests and ethnopharmacological investigations: Wound healing as an exampleJournal of Ethnopharmacology, 2005
- International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategiesBritish Journal of Dermatology, 2003